There are 108 resources available
Q&A and live discussion
Presenter: Javier Cortés
Session: Proffered Paper - Breast cancer, early stage
Resources:
Webcast
Invited Discussant LBA65 and 1525O
Presenter: Eileen O'Reilly
Session: Proffered Paper - GI, non colorectal
Resources:
Slides
Webcast
Invited Discussant 362O, 363O and 364O
Presenter: Emilie Le Rhun
Session: Proffered Paper - CNS tumours
Resources:
Slides
Webcast
Invited Discussant LBA11, 159O and 160O
Presenter: Sherko Kümmel
Session: Proffered Paper - Breast cancer, early stage
Resources:
Slides
Webcast
Invited Discussant LBA12 and 161O
Presenter: Serena Di Cosimo
Session: Proffered Paper - Breast cancer, early stage
Resources:
Slides
Webcast
CN34 - Management of immunotherapy toxicities: A new challenge
Presenter: Laura Bascuñana Sanchez
Session: EONS13: Immunotherapy and precision oncology: What do patients need?
Resources:
Abstract
Slides
Webcast
LBA11 - IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC)
Presenter: Nadia Harbeck
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
159O - Prognostic value of tumour infiltrating lymphocytes in young triple negative breast cancer patients who did not receive adjuvant systemic treatment; by the PARADIGM study group
Presenter: Vincent De Jong
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Webcast
160O - Survival analysis of the randomized phase III GeparOcto trial comparing neoadjuvant chemotherapy (NACT) of iddEPC versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer, TNBC) (PM(Cb)) for patients (pts) with high-risk early breast cancer (BC)
Presenter: Andreas Schneeweiss
Session: Proffered Paper - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
Genetic risk communication and risk assessment in cancer patients (genetic testing / counselling)
Presenter: Celia Díez de los Ríos de la Serna
Session: EONS13: Immunotherapy and precision oncology: What do patients need?
Resources:
Slides
Webcast